---
title: "Low-Intensity Focused Ultrasound Targeting the Amygdala for Depression and Anxiety: First-in-Human"
id: "medrxiv-8-low-intensity-focused-ultrasound-of-the-amygdala-in-depression-and-anxiety-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-8-low-intensity-focused-ultrasound-of-the-amygdala-in-depression-and-anxiety-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.18.26363360v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Low-Intensity Focused Ultrasound Targeting the Amygdala for Depression and Anxiety: First-in-Human
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-8-low-intensity-focused-ultrasound-of-the-amygdala-in-depression-and-anxiety-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.18.26363360v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This first-in-human, single-blind randomized crossover trial tested **low-intensity focused ultrasound (FUS)** targeting the right **amygdala** in 10 participants with major depressive disorder (ClinicalTrials.gov NCT05147142) using an active control (left primary somatosensory cortex). - The protocol delivered two 10-minute FUS applications per session within diagnostic ultrasound safety limits; nine participants completed both sessions. - Primary outcomes were safety and target engagement measured by BOLD fMRI during sonication, post-sonication arterial spin labeling (ASL) perfusion, and resting-state functional connectivity. - No serious adverse events occurred; neurological, neuropsychological, and MRI safety assessments were unremarkable. Adverse events overall were more frequent after amygdala sonication (p = 0.028) and one participant experienced clinical worsening after amygdala sonication requiring monitoring. - Amygdala sonication produced greater local perfusion change in the targeted amygdala and ipsilateral hippocampus compared with the control region (both p < 0.001). - BOLD fMRI during sonication engaged ventromedial prefrontal cortex and rostral anterior cingulate regions; post-sonication, resting-state connectivity between basolateral amygdala and sensorimotor regions decreased (corrected p values < 0.05). - Symptom improvement did not differ between amygdala and control conditions in group-level analyses; however, exploratory imaging–symptom relationships were observed. - Participants reported spontaneous subjective experiences of calm, clarity, or lightness after amygdala but not control sonication (p < 0.001). - The study was conducted under FDA Investigational Device Exemption G200146 and approved by the VA Providence Institutional Review Board; funders included NIMH, US Department of Veterans Affairs, Brain & Behavior Research Foundation, and Focused Ultrasound Foundation. - Authors report relevant disclosures for some investigators; all data produced are contained in the manuscript.
## Clinical Analysis & Structured Key Points
Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial | medRxiv Skip to main content Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial View ORCID Profile Amanda R Arulpragasam , Mascha van 't Wout-Frank , Yosef A Berlow , Emily Aiken , Alison Gorbatov , Ryan Van Patten , Julia G Gillotti , Hannah R Swearingen , Christiana R Faucher , Hannah Adams , Nicole C.R. McLaughlin , Israel Liberzon , Jennifer Barredo , Stephen Correia , Benjamin Greenberg , Noah S Philip doi: https://doi.org/10.64898/2026.09.18.26363360 Amanda R Arulpragasam 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Amanda R Arulpragasam Mascha van 't Wout-Frank 2 Brown University Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yosef A Berlow 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emily Aiken 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alison Gorbatov 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ryan Van Patten 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Julia G Gillotti 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hannah R Swearingen 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Christiana R Faucher 3 Department of Psychology, University of Minnesota-Twin Cities; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hannah Adams 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nicole C.R. McLaughlin 4 Butler Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Israel Liberzon 5 Texas A and M University Health Science Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jennifer Barredo 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Stephen Correia 6 Institute of Gerontology, University of Georgia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Benjamin Greenberg 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Noah S Philip 1 Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: noah_philip{at}brown.edu Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract ABSTRACT Background: Low intensity focused ultrasound (FUS) offers a noninvasive method for directly modulating deep brain structures with millimeter-scale precision, potentially addressing a major limitation of existing noninvasive neuromodulation approaches. The amygdala is a key node in affective neurocircuitry and a compelling target for psychiatric intervention. We conducted a first in human active controlled trial ( NCT05147142 ) of amygdala-targeted FUS in patients with major depressive disorder, examining safety and target engagement. Methods: Ten participants with major depressive disorder completed a single-blind randomized crossover trial with blinded symptom ratings, comparing imaging guided FUS targeting the right amygdala versus left primary somatosensory cortex as an active control. FUS comprised two 10 minute applications within diagnostic ultrasound safety limits. Primary outcomes were safety and target engagement assessed with BOLD fMRI during sonication, post-sonication arterial spin labeling (ASL) and resting state functional connectivity. Secondary and exploratory outcomes included symptom change and imaging x symptom relationships. Results: Nine participants completed both sessions. No serious adverse events occurred; neurological, neuropsychological, and MRI safety assessments were unremarkable. Adverse events were more frequent after amygdala than control sonication (p=0.028); one participant experienced clinical worsening following amygdala sonication and required monitoring. Amygdala sonication produced greater perfusion change in the targeted amygdala compared to the control region (p<0.001), and ipsilateral hippocampus (p<0.001). BOLD fMRI during sonication demonstrated engagement of ventromedial prefrontal and rostral anterior cingulate regions, while post sonication resting state connectivity decreased between basolateral amygdala and sensorimotor regions (corrected ps<0.05). Symptom improvement did not differ between conditions, but exploratory imaging x symptom relationships were significant. Spontaneous reports of calm, clarity, or lightness occurred after amygdala but not control sonication (p<0.001). Conclusions: Amygdala targeted FUS produced anatomically specific, multimodal evidence of neuromodulation relative to active control, with a manageable safety profile. Convergent target and circuit level signals support further development of FUS as a precision approach for modulating deep brain targets in psychiatric disorders. Key words: low-intensity focused ultrasound, amygdala, neuroimaging, depression, anxiety Competing Interest Statement DISCLOSURES: NSP is a consultant to Motif Neurotech and on the scientific advisory board for Pulvinar Neuro and Grey Matter Neurosciences, and reports royalties from UpToDate Inc., unrelated to the current work. He also serves as Deputy Editor of the American Journal of Psychiatry. MvWF is on the data and safety monitoring board for Pulvinar Neuro and Qortical Clinical Partners, Inc., unrelated to the current work. RVP reports royalties from the American Psychological Association, the International Neuropsychological Society, and Springer. SC receives research funding from Tarkett, USA, unrelated to the current work. All other authors have no biomedical conflicts of interests to disclose. Clinical Trial NCT05147142 IDE G200146 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The VA Providence Institutional Review Board gave ethical approval fro this work. Additionally, the study was determined to be Significant Risk by the US Food and Drug Administration and thus conducted under Investigational Device Exemption G200146 and registered at ClinicalTrials.gov ( NCT05147142 ). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared National Institute of Mental Health, https://ror.org/04xeg9z08 , U01 MH123427 US Department of Veterans Affairs , I50 RX002864 , I01RX005299 , V1CDA2024-75 , IK2 CX002603 Brain & Behavior Research Foundation, https://ror.org/03a63f080 Focused Ultrasound Foundation, https://ror.org/04qjbd269 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial Amanda R Arulpragasam , Mascha van 't Wout-Frank , Yosef A Berlow , Emily Aiken , Alison Gorbatov , Ryan Van Patten , Julia G Gillotti , Hannah R Swearingen , Christiana R Faucher , Hannah Adams , Nicole C.R. McLaughlin , Israel Liberzon , Jennifer Barredo , Stephen Correia , Benjamin Greenberg , Noah S Philip medRxiv 2026.09.18.26363360; doi: https://doi.org/10.64898/2026.09.18.26363360 Share This Article: Copy Citation Tools Low-Intensity Focused Ultrasound of the Amygdala in Depression and Anxiety: A First-in-Human Active-Controlled Trial Amanda R Arulpragasam , Mascha van 't Wout-Frank , Yosef A Berlow , Emily Aiken , Alison Gorbatov , Ryan Van Patten , Julia G Gillotti , Hannah R Swearingen , Christiana R Faucher , Hannah Adams , Nicole C.R. McLaughlin , Israel Liberzon , Jennifer Barredo , Stephen Correia , Benjamin Greenberg , Noah S Philip medRxiv 2026.09.18.26363360; doi: https://doi.org/10.64898/2026.09.18.26363360 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Psychiatry and Clinical Psychology Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4825) Dentistry and Oral Medicine (479) Dermatology (418) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15970) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7060) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5058) Health Policy (1436) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16302) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7290) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3613) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5916) Public and Global Health (9769) Radiology and Imaging (2431) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (781) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [More REM (dream) sleep linked to lower risk of 83 diseases—UK Biobank study](https://medichelpline.com/clinical-feed/medical-news-today-0-more-dream-sleep-linked-to-lower-risk-of-83-diseases-including-diabetes.md)
- [Circadian Rhythm Disturbances in Young Adults: Clinical, Functional and Genetic Correlates](https://medichelpline.com/clinical-feed/medrxiv-19-cumulative-indicators-of-circadian-rhythm-disturbance-and-its-clinical.md)
- [Carbon monoxide exposure may explain lower Parkinson's risk linked to smoking](https://medichelpline.com/clinical-feed/medical-news-today-0-why-smokers-may-have-a-lower-parkinson-s-risk-it-s-not-the-nicotine.md)
- [Feasibility of SMS Screening for Mood Disturbances After Minor Stroke](https://medichelpline.com/clinical-feed/medrxiv-14-feasibility-of-sms-based-screening-for-mood-disturbances-after-minor-stroke.md)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.